A late researcher in Italy who has already been blamed for image manipulation in a PLOS ONE retraction notice has had two more papers retracted, both from Free Radical Biology and Medicine.
Here’s the notice for 2007’s “Redox regulation of 7-ketocholesterol-induced apoptosis by β-carotene in human macrophages,” by Paola Palozza and colleagues: Continue reading Deceased researcher has two more papers retracted
The recent retraction of a paper in Science Translational Medicine reporting “one of the biggest things to happen” in narcolepsy research has claimed a bystander: A letter that commented on the no-longer-landmark article.
The authors of the letter are with GlaxoSmithKline’s vaccine division. Here’s the new notice: Continue reading Downstream effects: Comment on retracted narcolepsy paper retracted
PLoS One has retracted a 2013 article on atherosclerosis in mice over concerns about the integrity of the data.
The paper, “The Effect of Soluble RAGE on Inhibition of Angiotensin II-Mediated Atherosclerosis in Apolipoprotein E Deficient Mice,” came from a group of researchers in South Korea.
It purported to show that: Continue reading Data questions prompt retraction of PLOS ONE cardiovascular paper
The European Heart Journal has issued an expression of concern for a 2014 2001 paper by Don Poldermans, the Dutch heart researcher who stepped down from his post at Erasmus University after being accused of misconduct.
The article, “Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery,” appeared in July and reported data from the DECREASE trial. Poldermans, who left Erasmus in 2011, has acknowledged failing to receive informed consent from some patients in one phase of the DECREASE study but denied having fabricated results.
According to the notice: Continue reading “Wide differences in the memories” prompt expression of concern for Poldermans paper
Here at Retraction Watch, we don’t believe in the expression “TMI.” But this case features a level of detail we’re not sure we’ve seen before.
Acta Radiologica has pulled a 2012 article on breast cancer imaging for being a duplicate publication — a sin the retraction notice takes great pains to point out.
The notice, written by journal editor Arnulf Skjennald, has the blow-by-blow feel of a police report: Continue reading Retraction, tell-all style, for breast cancer radiology paper
A group of liver researchers from the University of Pittsburgh has earned a pair of corrections in Hepatology for image problems.
The team was led by George K. Michalopoulos, chair of the department of pathology at the University of Pittsburgh Medical Center.
One article, “Excessive hepatomegaly of mice with hepatocyte-targeted elimination of integrin linked kinase following treatment with 1,4-bis [2-(3,5-dichaloropyridyloxy)] benzene,” appeared in January 2011. According to the notice: Continue reading Hepatology issues corrections in two papers from Pitt liver group
A chemical engineering paper published in February has been retracted for data and authorship problems.
According to the retraction notice, the authors’ institutions investigated and found that not only was the data not reproducible, but “not all co-authors on the manuscript were aware of or agreed to the content and scientific conclusions in the article.”
Here’s the notice in the Journal of Chemical & Engineering Data for “Ionic Liquids as Promising Solvents for Biomass Derived Mannitol and Xylitol”: Continue reading Solvent paper dissolves under heat of institutional investigation
Karel Bezouška, a researcher who broke into a lab refrigerator to tamper with an investigation into his work, has nine retractions.
Here’s the retraction notice in Biochemistry for 2010’s “Cooperation between Subunits Is Essential for High-Affinity Binding of N-Acetyl-d-hexosamines to Dimeric Soluble and Dimeric Cellular Forms of Human CD69:” Continue reading Researcher who broke into lab up to nine retractions
A group of researchers from Egypt has lost their 2013 article on hepatitis C in the Journal of Immunoassay and Immunochemistry for fudging their figures.
The article was titled “In vitro neutralization of HCV by goat antibodies against peptides encompassing regions downstream of HVR-1 of E2 glycoprotein.” According to the abstract: Continue reading Image manipulation forces retraction of hepatitis C paper
As we’ve pointed out before, economics and business journals have few retractions compared with the other academic literature. Opinions vary on why this is, but the fact that only a few journals have plagiarism policies can’t help.
Research Papers in Economics, or RePEc, an organization that maintains a database of economics papers, however, thoroughly investigates accusations of misconduct. A RePEc report, which indicated that the plagiarists were polite enough to cite the original paper, was used in the notice as evidence for a retraction in Economic Modelling.
Here’s the notice for “Retraction notice to “Analysis of nonlinear duopoly game with heterogeneous players”: Continue reading Economics paper retracted for plagiarism after citing its twin